Macerich Prices Upsized $403.2M Public Offering at $21.00/Share, Funds Annapolis Mall Acquisition

summarizeSummary

Macerich priced an upsized public offering of 19.2 million shares at $21.00 each, raising $403.2 million to repay debt from the Annapolis Mall acquisition and for general corporate purposes, resulting in significant dilution.

check_boxKey Events

• Upsized Public Offering Priced

  Macerich priced an upsized public offering of 19.2 million shares of common stock at $21.00 per share, with underwriters having an option for an additional 2.88 million shares. This finalizes the terms of an offering initiated on May 11, 2026.

• Significant Capital Raise

  The offering is expected to generate gross proceeds of $403.2 million, or up to $463.68 million if the underwriters' option is fully exercised, providing substantial capital for the company.

• Dilution to Existing Shareholders

  The issuance of up to 22.08 million new shares (with full option exercise) represents approximately 8.45% dilution to the 261.38 million shares outstanding as of May 8, 2026.

• Proceeds for Debt Repayment and Growth

  Net proceeds will primarily repay borrowings under the revolving credit facility, which funded the recent $272 million Annapolis Mall acquisition, and support general corporate purposes and strategic investments at the mall.

auto_awesomeAnalysis

Macerich has finalized the terms and pricing of its public offering, selling 19.2 million shares at $21.00 per share, with potential gross proceeds of $403.2 million. This offering, which includes an option for underwriters to purchase an additional 2.88 million shares, represents a significant capital raise. The proceeds are primarily earmarked to repay borrowings under its revolving credit facility, which were used to fund the recent $272 million acquisition of Annapolis Mall, and for general corporate purposes. While the offering is dilutive to existing shareholders (approximately 8.45% based on shares outstanding before the offering and maximum shares offered), it provides crucial capital to strengthen the balance sheet following a major acquisition and supports future strategic investments. The pricing at a moderate discount to the last reported share price indicates a necessary capital infusion rather than a premium offering.